PD-L2 is a second ligand for PD-1 and inhibits T cell activation

Yvette Latchman(Brigham and Women's Hospital), Clive R. Wood, Tatyana Chernova(Harvard University), Divya Chaudhary, Madhuri Borde(Brigham and Women's Hospital), Irene Chernova(Harvard University), Yoshiko Iwai(Kyoto University), Andrew J. Long, Julia A. Brown(Harvard University), Raquel Nunes(Harvard University), Edward Greenfield(Dana-Farber Cancer Institute), Karen Bourque, Vassiliki A. Boussiotis(Dana-Farber Cancer Institute), Laura Carter, Beatriz M. Carreno, Nelly Malenkovich(Harvard University), Hiroyuki Nishimura(Kyoto University), Taku Okazaki(Kyoto University), Tasuku Honjo(Kyoto University), Arlene H. Sharpe(Brigham and Women's Hospital), Gordon J. Freeman(Harvard University)
Nature Immunology
March 1, 2001
Cited by 2,945

Abstract


Related Papers

No related papers found

Powered by citation graph analysis